Clinical trials
Observational Cardiomyopathies trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2011 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 8 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 4 |
| Barts & The London NHS Trust | 2 |
| NHS Greater Glasgow and Clyde | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alnylam Pharmaceuticals | 1 |
| Bayer | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| King's College London | 1 |
| Manchester University NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 25 |
| Heart Failure | 6 |
| Cardiomyopathy, Dilated | 4 |
| Arrhythmias, Cardiac | 3 |
| Cardiomyopathy, Hypertrophic | 3 |
| Heart Diseases | 3 |
| Arrhythmogenic Right Ventricular Dysplasia | 2 |
| Atrial Fibrillation | 2 |
| Cardiotoxicity | 2 |
| Cardiovascular Diseases | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.